August 07, 2026 — RNews

#herpesvirus — Friday, August 07, 2026 (1 items)

hot top new

← prev day next day →

0

The efficacy, immunogenicity and safety of the LZ901 vaccine for herpes zoster virus in adults 40 years of age or older: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. (nature.com)

Jin P … Li J Nature Communications 2026-08-07

#vaccination #clinical trial #immunogenicity #herpesvirus #efficacy